Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference

Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference

posted on Feb 09, 2020 07:21AM

Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference

https://www.bioasis.us/bioasis-to-present-at-the-22nd-annual-bio-ceo-investor-conference-and-the-otc-markets-2020-virtual-investor-conference/

Feb 6, 2020,

GUILFORD, Conn.–(Business Wire)– Bioasis Technologies Inc. (OTCQB:BIOAF)(TSX.V:BTI), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that Dr. Deborah Rathjen, Executive Chair and Chief Executive Officer of Bioasis will present at the following conferences:

22nd Annual Bio CEO Investor Conference (February 10–11, 2020)

Bioasis company presentation on Monday, February 10, 2020 at 10:00 a.m. ET in the Ziegfeld Room on the Fourth Floor at New York Marriott Marquis, New York, NY.

OTC Markets 2020 Virtual Investor Conference (February 20, 2020)

Bioasis company presentation on Thursday, February 20, 2020 at 11:30 a.m. ET. Please register or loginat the Virtual Investor Conferences website to view the presentation.

Share
New Message
Please login to post a reply